Cogent Biosciences, Inc. (COGT)
36.70
-2.82
(-7.15%)
USD |
NASDAQ |
Jan 23, 16:00
36.70
0.00 (0.00%)
After-Hours: 17:13
Cogent Biosciences Research and Development Expense (TTM): 251.67M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Pfizer Inc. | 10.13B |
| Ionis Pharmaceuticals, Inc. | 879.75M |
| Cidara Therapeutics, Inc. | 131.82M |
| Olema Pharmaceuticals, Inc. | 146.78M |
| ADMA Biologics, Inc. | 3.776M |